No evidence for a pathogen associated with pulmonary MALT lymphoma: a metagenomics investigation.


Journal

Infectious agents and cancer
ISSN: 1750-9378
Titre abrégé: Infect Agent Cancer
Pays: England
ID NLM: 101276559

Informations de publication

Date de publication:
06 Feb 2021
Historique:
received: 26 11 2020
accepted: 28 01 2021
entrez: 7 2 2021
pubmed: 8 2 2021
medline: 8 2 2021
Statut: epublish

Résumé

Mucosa-associated lymphoid tissue (MALT) lymphoma is generally associated with chronic antigen stimulation: auto-antigens or of microbial origin. Only one study suggested association between Achromobacter xylosoxidans and pulmonary MALT lymphoma. We aimed to investigate the presence of virus or any infectious agents in pulmonary MALT lymphoma by using metagenomic next-generation sequencing (mNGS).All lung samples were centrally reviewed. The t(11;18) (q21;q21) was evaluated by FISH analysis. The snap frozen large lung biopsies were analyzed by mNGS. After lung biopsies homogenization total nucleic acids (RNA and DNA) were extracted, amplified and classified according to their taxonomic assignment, after exclusion of host DNA.We included 13 samples from pulmonary MALT lymphoma (mean age: 60.3 years, 7 women, 3 with auto-immune background) and 10 controls. The diagnosis of MALT lymphoma was confirmed for the 13 samples, 3 showed API2-MALT1 translocation (23%). No evidence of the presence of a specific pathogen was clearly identified in the group of patients with pulmonary MALT lymphoma. We identifiedA. xylosoxidans sequence in 4/13 patients and in 4/10 controls.This study did not find evidence for a DNA or RNA virus, a fungi, a parasite or a bacteria associated with pulmonary MALT lymphoma either in the stroma or in tumor cells.

Identifiants

pubmed: 33549143
doi: 10.1186/s13027-021-00351-w
pii: 10.1186/s13027-021-00351-w
pmc: PMC7868019
doi:

Types de publication

Journal Article

Langues

eng

Pagination

10

Subventions

Organisme : Assistance Publique - Hôpitaux de Paris (FR)
ID : CRC 2013-006 DRCI APHP

Références

Am J Clin Pathol. 2011 Jan;135(1):70-5
pubmed: 21173126
Aliment Pharmacol Ther. 2019 Sep;50(6):654-663
pubmed: 31347731
J Pathol. 2006 Jul;209(3):344-51
pubmed: 16583361
J Clin Oncol. 2005 Sep 10;23(26):6415-20
pubmed: 16155028
Eur Respir J. 2009 Dec;34(6):1408-16
pubmed: 19541720
Nat Rev Genet. 2019 Jun;20(6):341-355
pubmed: 30918369
Br J Haematol. 2014 Mar;164(6):804-10
pubmed: 24372375
Am J Surg Pathol. 2006 Dec;30(12):1546-53
pubmed: 17122510
N Engl J Med. 1994 May 5;330(18):1267-71
pubmed: 8145781
Annu Rev Physiol. 2016;78:481-504
pubmed: 26527186
J Clin Oncol. 2005 Oct 1;23(28):7060-8
pubmed: 16129841
Blood. 2008 Apr 15;111(8):4029-38
pubmed: 18263783
Blood. 2006 Apr 15;107(8):3034-44
pubmed: 16397126
Leukemia. 2004 Oct;18(10):1722-6
pubmed: 15356642
Eur J Clin Microbiol Infect Dis. 2000 Aug;19(8):644-5
pubmed: 11014633
Blood. 2016 May 19;127(20):2375-90
pubmed: 26980727
Lancet. 2001 Jan 6;357(9249):39-40
pubmed: 11197361

Auteurs

Raphaël Borie (R)

Service de Pneumologie A, Centre de référence des maladies pulmonaires rares, AP-HP, Hôpital Bichat and Université de Paris and INSERM U1152, Paris, France. raphael.borie@aphp.fr.

Valérie Caro (V)

Environment and Infectious Risks unit, Institut Pasteur, Paris, France.

Hilario Nunes (H)

Service de Pneumologie, Centre de référence des maladies pulmonaires rares, AP-HP, Hôpital Avicenne, Bobigny, France.

Marianne Kambouchner (M)

Service d'Anatomie pathologique, AP-HP, Hôpital Avicenne, Bobigny, France.

Aurélie Cazes (A)

Service d'Anatomie pathologique, AP-HP, Hôpital Bichat, Paris, France.

Martine Antoine (M)

Service d'Anatomie pathologique, AP-HP, Hôpital Tenon and GRC#4 Theranoscan Sorbonne Université, Paris, France.

Bruno Crestani (B)

Service de Pneumologie A, Centre de référence des maladies pulmonaires rares, AP-HP, Hôpital Bichat and Université de Paris and INSERM U1152, Paris, France.

Karen Leroy (K)

Laboratoire de Biologie et génétique moléculaire, APHP, Hôpital Cochin, Paris, France.

Christiane Copie-Bergman (C)

Département de Pathologie, APHP, Groupe Henri Mondor-Albert Chenevier, INSERM U955, Université Paris Est, F-94010, Creteil, France.

Aurelia Kwasiborski (A)

Environment and Infectious Risks unit, Institut Pasteur, Paris, France.

Christophe Hennequin (C)

Service de Parasitologie-Mycologie, Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, AP-HP, Hôpital Saint-Antoine, F-75012, Paris, France.

Mathias Vandenbogaert (M)

Environment and Infectious Risks unit, Institut Pasteur, Paris, France.

Véronique Hourdel (V)

Environment and Infectious Risks unit, Institut Pasteur, Paris, France.

Jacques Cadranel (J)

Service de Pneumologie et Oncologie thoracique, Centre de référence des maladies pulmonaires rares, AP-HP, Hôpital Tenon and GRC#4 Theranoscan, Sorbonne Université, Paris, France.

Classifications MeSH